(Q50267725)

28 February 2018

title

Gene expression signatures and ex vivo drug sensitivity profiles in children with acute lymphoblastic leukemia. (English)

1 reference

28 February 2018

9

Barbara Jarzab

1 reference

28 February 2018

Joanna Szczepanek

1 reference

28 February 2018

Małgorzata Kowalska

Małgorzata Kowalska

1 reference

28 February 2018

Andrzej Tretyn

Andrzej TRETYN

1 reference

28 February 2018

Jan Styczyński

10

Jan Styczynski

1 reference

28 February 2018

Olga Haus

6

Olga Haus

1 reference

28 February 2018

Mariusz Wysocki

8

Mariusz Wysocki

1 reference

28 February 2018

Malgorzata Oczko-Wojciechowska

3

Malgorzata Oczko-Wojciechowska

1 reference

28 February 2018

Michał Jarząb

2

Michal Jarzab

1 reference

28 February 2018

Monika Pogorzała

7

Monika Pogorzala

1 reference

28 February 2018

publication date

27 October 2011

1 reference

28 February 2018

Journal of Applied Genetics

published in

1 reference

28 February 2018

volume

53

1 reference

28 February 2018

issue

1

1 reference

28 February 2018

page(s)

83-91

1 reference

28 February 2018

https://scigraph.springernature.com/pub.10.1007/s13353-011-0073-x

exact match

0 references

cites work

The PIK3CA gene is mutated with high frequency in human breast cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

New developments in microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Phylogenomics of phosphoinositide lipid kinases: perspectives on the evolution of second messenger signaling and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Moving towards individualized medicine with pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Association of gastric cancer, HLA-DQA1, and infection with Helicobacter pylori CagA+ and VacA+ in a Mexican population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Functional analysis of PIK3CA gene mutations in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Risk-adapted treatment of pediatric acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

The Nudix hydrolase superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Structures and mechanisms of Nudix hydrolases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Treating childhood acute lymphoblastic leukemia without cranial irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Oncogenic PI3K and its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Profiling of regulatory microRNA transcriptomes in various biological processes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Genome-wide expression analysis of paired diagnosis-relapse samples in ALL indicates involvement of pathways related to DNA replication, cell cycle and DNA repair, independent of immune phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Is the in vitro drug resistance profile the strongest prognostic factor in childhood acute lymphoblastic leukemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

RhoG regulates gene expression and the actin cytoskeleton in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13353-011-0073-X

Clinical significance of P-glycoprotein in multidrug resistance malignancies.

21 January 2018

1 reference

12 December 2020

Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway

1 reference

12 December 2020

Acute lymphoblastic leukemia

1 reference

12 December 2020

Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemia.

1 reference

12 December 2020

Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia

1 reference

12 December 2020

Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein

1 reference

12 December 2020

Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites

1 reference

12 December 2020

The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia

1 reference

12 December 2020

[Gene expression profiles in acute lymphoblastic leukemia in children and adults]

1 reference

12 December 2020

In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia

1 reference

12 December 2020

[DNA microarrays and papillary thyroid carcinoma gene expression profile]

1 reference

12 December 2020

Toward a total cure for acute lymphoblastic leukemia

1 reference

12 December 2020

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

12 December 2020

10.1007/S13353-011-0073-X

Identifiers

DOI

1 reference

28 February 2018

1 reference

28 February 2018